The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...
The FDA approved Wegovy’s first oral obesity pill, offering similar weight loss to injectables. Daily dosing could expand access, reduce costs, and broaden obesity treatment options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback